Healthcare - Biotechnology - NASDAQ - FR
$ 2.72
2.26 %
$ 236 M
Market Cap
-1.25
P/E
BALANCE SHEET
69.6 M
ASSETS
102 M
LIABILITIES
-32 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Inventiva S.A.
| Current Assets | 48.2 M |
| Cash & Short-Term Investments | 26.9 M |
| Receivables | 3.81 M |
| Other Current Assets | 17.5 M |
| Non-Current Assets | 21.4 M |
| Long-Term Investments | 1.42 M |
| PP&E | 9.13 M |
| Other Non-Current Assets | 10.8 M |
| Current Liabilities | 50.2 M |
| Accounts Payable | 37.7 M |
| Short-Term Debt | 5.31 M |
| Other Current Liabilities | 7.17 M |
| Non-Current Liabilities | 51.4 M |
| Long-Term Debt | 29.9 M |
| Other Non-Current Liabilities | 21.6 M |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||
| Cash & Cash Equivalents | 26.9 | 86.7 | 86.6 | 105.7 | 35.8 | 56.7 | 59.1 | 24.9 | 22.6 | 17.1 | 13.5 |
| Short Term Investments | 0 | 1.0 | 8.8 | 7.3 | 0 | 0 | 3.11 K | 0 | 0 | 0 | 0 |
| Receivables | 3.8 | 1 | 4.0 | 48 K | 4 K | 6 K | 64 K | 4.5 | 0.9 | 0.8 | 0.8 |
| Inventory | 0.4 | 0.4 | 0.4 | 0.3 | 0.4 | 0.4 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 |
| Other Current Assets | 5.1 | 8.9 | 8.2 | 6.1 | 0.8 | 1.2 | 7.6 | 11.4 | 5.5 | 3.1 | 1.3 |
| Total Current Assets | 48.2 | 106.4 | 115.6 | 133.0 | 48.9 | 71.6 | 67.2 | 41.2 | 28.6 | 21.5 | 16.2 |
| PP&E | 9.1 | 7.4 | 3.2 | 3.3 | 3.7 | 4.3 | 4.5 | 5.0 | 5.6 | 5.9 | 6.0 |
| Intangible Assets | 0.5 | 0.6 | 0.8 | 0.9 | 1.2 | 1.5 | 1.8 | 2.1 | 2.4 | 2.2 | 2.0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 1.4 | 0.7 | 1.7 | 1.7 | 2.3 | 2.3 | 0.2 | 0.4 | 23.5 | 0 | 0 |
| Other Long Term Assets | 10.3 | 1.0 | 2 K | 8 K | 3.1 | 2.4 | 0.3 | 0 | 0.4 | 43.4 | 62.8 |
| Other Assets | 1 | 1 K | 3 K | 0 | 3 K | 1 K | 0 | 2 | 3 | 0 | 0 |
| Total Assets | 69.6 | 116.0 | 122.0 | 138.9 | 57.0 | 79.8 | 74.4 | 48.9 | 60.6 | 73.1 | 87.1 |
| LIABILITIES | |||||||||||
| Accounts Payable | 37.7 | 19.4 | 14.6 | 6.9 | 7.5 | 8.4 | 5.4 | 4.4 | 3.6 | 1.9 | 1.7 |
| Short Term Debt | 5.3 | 5.9 | 1.3 | 18 K | 0.1 | 2.1 | 0.3 | 0.1 | 0.2 | 58.7 K | 60.9 K |
| Other Current Liabilities | 3.6 | 3.4 | 5.9 | 6.1 | 5.4 | 3.3 | 1.7 | 3.3 | 2.1 | 1.9 | 2.1 |
| Total Current Liabilities | 50.2 | 30.7 | 22.9 | 13.9 | 13.9 | 15.1 | 8.8 | 8.6 | 7.7 | 5.5 | 5.6 |
| Long Term Debt | 29.9 | 28.7 | 8.8 | 10.0 | 2 K | 74 K | 0.2 | 0.5 | 0.5 | 45.7 K | 99.4 K |
| Deferred Tax Income | 0 | 0 | 0 | 0 | 0 | 0 | (1.9) | 3.0 | 9.1 | 15.7 | 22.2 |
| Other Liabilities | 21.5 | 11.1 | 1.4 | 3.8 | 1.7 | 3.1 | 1.3 | 0.9 | 9.1 | 0.3 | 22.4 |
| Total Liabilities | 101.6 | 70.5 | 33.1 | 27.7 | 15.6 | 18.2 | 10.4 | 13.1 | 17.8 | 21.6 | 28.1 |
| EQUITY | |||||||||||
| Common Stock | 0.5 | 0.4 | 0.4 | 0.4 | 0.3 | 0.2 | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 |
| Retained Earnings | (110.4) | (54.3) | (49.6) | (33.6) | (30.2) | (33.6) | (17.2) | (7.0) | (8.8) | (7.5) | (7.1) |
| Other Accumulative Comprehensive Income/Loss | (234.4) | (74.6) | (27.0) | 4.8 | (14.7) | 17.5 | 36.1 | 42.7 | 51.5 | 58.9 | 66.0 |
| Total Equity | (32.0) | 45.5 | 88.9 | 111.2 | 41.4 | 61.6 | 64.0 | 35.7 | 42.8 | 51.5 | 59.0 |
| Total Liabilities and Equity | 69.6 | 116.0 | 122.0 | 138.9 | 57.0 | 79.8 | 74.4 | 48.9 | 60.6 | 73.1 | 87.1 |
| SHARES OUTSTANDING | |||||||||||
| Common Shares Outstanding | 45.4 | 41.4 | 39.2 | 33.9 | 23.5 | 20.5 | 15.5 | 15.7 | 10.0 | 10.0 | 10.0 |